
Opinion|Videos|April 24, 2024
Impressions on Safety Data from EMERALD Subgroup Analysis
Expert perspectives on safety data from the EMERALD subgroup analysis, highlighting endocrine therapy–related adverse effects and supportive care strategies.
Expert perspectives on safety data from the EMERALD subgroup analysis, highlighting endocrine therapy–related adverse effects and supportive care strategies.